99 related articles for article (PubMed ID: 7578938)
1. Synthesis and biological activity of tripeptide FR113680 analogues containing unconventional amino acids.
Caliendo G; Calignano A; Grieco P; Mancuso F; Perissutti E; Santini A; Santagada V
Biopolymers; 1995 Oct; 36(4):409-14. PubMed ID: 7578938
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro activities of highly potent and selective tripeptide antagonists of the neurokinin NK-1 receptor.
Caliendo G; Greco G; Grieco P; Perissutti E; Santagada V; Calignano A; Mancuso F; Novellino E
Farmaco; 1995 Nov; 50(11):755-9. PubMed ID: 8593172
[TBL] [Abstract][Full Text] [Related]
3. Modification of the potent peptide FK888 with unusual aminoacids: effects on activity on neurokinin receptors.
Caliendo G; Greco G; Grieco P; Perissutti E; Santagada V; Calignano A; Mancuso F; Novellino E
Farmaco; 1996 Mar; 51(3):197-201. PubMed ID: 8688142
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of dimeric analogs of neurokinin A and B: effect of dimerization of COOH-terminal heptapeptides on receptor selection.
Sakaguchi K; Kodama H; Matsumoto H; Yoshida M; Takano Y; Kamiya H; Waki M; Shimohigashi Y
Pept Res; 1989; 2(5):345-51. PubMed ID: 2485210
[TBL] [Abstract][Full Text] [Related]
5. Beta-methyl substitution of cyclohexylalanine in Dmt-Tic-Cha-Phe peptides results in highly potent delta opioid antagonists.
Tóth G; Ioja E; Tömböly C; Ballet S; Tourwé D; Péter A; Martinek T; Chung NN; Schiller PW; Benyhe S; Borsodi A
J Med Chem; 2007 Jan; 50(2):328-33. PubMed ID: 17228874
[TBL] [Abstract][Full Text] [Related]
6. Cyclic pentapeptides of chiral sequence DLDDL as scaffold for antagonism of G-protein coupled receptors: synthesis, activity and conformational analysis by NMR and molecular dynamics of ITF 1565 a substance P inhibitor.
Porcelli M; Casu M; Lai A; Saba G; Pinori M; Cappelletti S; Mascagni P
Biopolymers; 1999 Aug; 50(2):211-9. PubMed ID: 10380345
[TBL] [Abstract][Full Text] [Related]
7. A new class of pseudopeptide antagonists of the kinin B1 receptor containing alkyl spacers.
Galoppini C; Meini S; Tancredi M; Di Fenza A; Triolo A; Quartara L; Maggi CA; Formaggio F; Toniolo C; Mazzucco S; Papini A; Rovero P
J Med Chem; 1999 Feb; 42(3):409-14. PubMed ID: 9986712
[TBL] [Abstract][Full Text] [Related]
8. Side chain methyl substitution in the delta-opioid receptor antagonist TIPP has an important effect on the activity profile.
Tourwé D; Mannekens E; Diem TN; Verheyden P; Jaspers H; Tóth G; Péter A; Kertész I; Török G; Chung NN; Schiller PW
J Med Chem; 1998 Dec; 41(26):5167-76. PubMed ID: 9857087
[TBL] [Abstract][Full Text] [Related]
9. Bradykinin receptor antagonists containing N-substituted amino acids: in vitro and in vivo B(2) and B(1) receptor antagonist activity.
Goodfellow VS; Marathe MV; Kuhlman KG; Fitzpatrick TD; Cuadrado D; Hanson W; Zuzack JS; Ross SE; Wieczorek M; Burkard M; Whalley ET
J Med Chem; 1996 Mar; 39(7):1472-84. PubMed ID: 8691478
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of 1-aminocycloalkane-1-carboxylic acid-substituted deltorphin analogues: unique delta and mu opioid activity in modified peptides.
Breveglieri A; Guerrini R; Salvadori S; Bianchi C; Bryant SD; Attila M; Lazarus LH
J Med Chem; 1996 Feb; 39(3):773-80. PubMed ID: 8576920
[TBL] [Abstract][Full Text] [Related]
11. Selective opioid dipeptides.
Temussi PA; Salvadori S; Amodeo P; Bianchi C; Guerrini R; Tomatis R; Lazarus LH; Picone D; Tancredi T
Biochem Biophys Res Commun; 1994 Feb; 198(3):933-9. PubMed ID: 8117299
[TBL] [Abstract][Full Text] [Related]
12. Role for NK(1) and NK(2) receptors in the motor activity in mouse colon.
Mulè F; Amato A; Serio R
Eur J Pharmacol; 2007 Sep; 570(1-3):196-202. PubMed ID: 17597603
[TBL] [Abstract][Full Text] [Related]
13. Highly selective bradykinin agonists and antagonists with replacement of proline residues by N-methyl-D- and L-phenylalanine.
Reissmann S; Schwuchow C; Seyfarth L; Pineda De Castro LF; Liebmann C; Paegelow I; Werner H; Stewart JM
J Med Chem; 1996 Feb; 39(4):929-36. PubMed ID: 8632416
[TBL] [Abstract][Full Text] [Related]
14. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
[TBL] [Abstract][Full Text] [Related]
15. Evidence for adrenergic and tachykinin activity in venom of the stonefish (Synanceja trachynis).
Hopkins BJ; Hodgson WC; Sutherland SK
Toxicon; 1996 May; 34(5):541-54. PubMed ID: 8783449
[TBL] [Abstract][Full Text] [Related]
16. [Synthesis and analysis of des-Met5-[D-Ala2]enkephalinamide analogs].
Vlasov GP; Gusel' VA; Kozhevnikova NIu; Pavlov VN; Illarionova NG
Bioorg Khim; 1986 May; 12(5):591-8. PubMed ID: 3015152
[TBL] [Abstract][Full Text] [Related]
17. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
Cialdai C; Tramontana M; Patacchini R; Lecci A; Catalani C; Catalioto RM; Meini S; Valenti C; Altamura M; Giuliani S; Maggi CA
Eur J Pharmacol; 2006 Nov; 549(1-3):140-8. PubMed ID: 16979621
[TBL] [Abstract][Full Text] [Related]
18. Analogues of a potent oxytocin antagonist with truncated C-terminus or shorter amino acid side chain of the basic amino acid at position 8.
Flouret G; Chaloin O; Slaninová J
J Pept Sci; 2003 Jun; 9(6):393-401. PubMed ID: 12846485
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro activities of NK-1 antagonists derived from L-tryptophan.
Caliendo G; Fiorino F; Grieco P; Perissutti E; Santagada V; Calignano A; Mancuso F; Albrizio S
Farmaco; 1997 Oct; 52(10):589-93. PubMed ID: 9507670
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and characterization of potent and selective mu-opioid receptor antagonists, [Dmt(1), D-2-Nal(4)]endomorphin-1 (Antanal-1) and [Dmt(1), D-2-Nal(4)]endomorphin-2 (Antanal-2).
Fichna J; do-Rego JC; Chung NN; Lemieux C; Schiller PW; Poels J; Broeck JV; Costentin J; Janecka A
J Med Chem; 2007 Feb; 50(3):512-20. PubMed ID: 17266203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]